AI

Augment Investments

Europe, England, United Kingdom, London

Description

Augment Investments is a venture capital firm specialized in early and later stage venture investments.

Investor Profile

Augment Investments has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series C (50%)

Country Focus

  • United States (50%)
  • Canada (50%)

Industry Focus

  • Cloud Computing
  • Data Management
  • Financial Services
  • Fintech
  • Information Technology
  • Software
  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Augment Investments frequently co-invest with?

Ventures West
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
Augment Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
Shah Capital Partners
North America, California, United States, Santa Clara
Co-Investments: 1
Inbio Ventures
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
Vision Ridge Capital Partners
North America, Colorado, United States, Boulder
Co-Investments: 1
BB
North America, New York, United States, New York
Co-Investments: 1

Which angels does Augment Investments often collaborate with?

FF
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Augment Investments?

Mercatus

San Mateo, California, United States

Mercatus is the modern investment data management platform for private markets.

Cloud ComputingData ManagementFinancial ServicesFinTechInformation TechnologySoftware
Series AJun 10, 2013
Amount Raised: $2,070,294
Aquinox Pharmaceuticals

Vancouver, British Columbia, Canada

Aquinox Pharmaceuticals develops and commercializes small molecule therapeutics for the treatment of cancer and inflammatory diseases.

BiotechnologyHealth CareTherapeutics
Series CApr 3, 2013
Amount Raised: $18,000,000